Minova Life Science

Minova life sciences - Pharmaceutical company

Fexocon-M Tablets


Fexofenadine Hydrochloride IP 120 mg + Montelukast IP 10mg


Fexocon-M Tablets


  • Fexofenadine
  1. An H, an antihistamine drug, shows efficacy and safety in the prevention of seasonal allergic rhinitis’
  2.  First-line medicine for the treatment of allergic rhino conjunctivitis Provides relief from the typical symptoms of hay fever.
  • Montelukast
  1. A leukotriene receptor antagonist, effective in improving daytime and night-time symptoms of allergic rhinitis
  2. Useful in maintenance therapy of asthma.
  3.  The combination of fexofenadine plus montelukast is more effective compared to fexofenadine alone in the control of allergic rhinitis symptoms
  4. A fixed dose combination of Montelukast and fexofenadine is effective in reducing all the individual nasal symptoms as nasal congestion, rhinorrhea, nasal itching, and sneezing

Explore other products

Scroll to Top